Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing…

Continue Reading
AI-Driven Blood Testing Consolidates Multiple Tests Efficiently

AI-Driven Blood Testing Consolidates Multiple Tests Efficiently

HN Summary 1. AI-powered precision blood testing: Dr. Guillaume Paré and his team at Hamilton Health…

Continue Reading
AI predicts health outcomes for premature newborns from blood samples

AI predicts health outcomes for premature newborns from blood samples

An artificial intelligence-based tool can predict the medical trajectories of individual premature newborns from blood samples…

Continue Reading
Hackensack Meridian Health Partners with DELFI Diagnostics, Supported by a Grant From Lilly to Improve Lung Cancer Screening Adherence with Innovative Blood Test

Hackensack Meridian Health Partners with DELFI Diagnostics, Supported by a Grant From Lilly to Improve Lung Cancer Screening Adherence with Innovative Blood Test

Newswise — HACKENSACK, NJ – (December 1, 2025) – The Hackensack Meridian Hennessy Institute for Cancer…

Continue Reading

C2N Diagnostics Awarded Rigorous New York State Department of Health Permit, Expanding Ability to Provide Its Blood Tests to Help Diagnose Alzheimer’s Disease

Classified in: Health, Science and technologySubjects: Product/Service, Business Update C2N Diagnostics, LLC (“C2N”) announces it has…

Continue Reading
Hundreds of Queensland babies may have missed vital newborn blood screening tests

Hundreds of Queensland babies may have missed vital newborn blood screening tests

Hundreds of Queensland babies may have missed out on receiving their vital newborn blood screening test…

Continue Reading